Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral diacerein for symptom relief in knee osteoarthritis
ChiCTR2300069578Phase 4Not yet recruiting
- Sponsor
- Xiangya Hospital, Central South University
- Start
- Apr 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diacerein in knee osteoarthritis (OA), sponsored by Xiangya Hospital, Central South University. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
diacerein
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2300069578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069578.